{
"id":"mk19_b_cv_f11",
"number":11,
"bookId":"cv",
"legend":{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Initial management of non–ST-elevation acute coronary syndromes. NSTEMI = non–ST-elevation myocardial infarction; UA = unstable angina; UFH = unfractionated heparin."
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Clopidogrel or ticagrelor may be administered at the time of hospital admission and diagnosis of acute coronary syndrome."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"If coronary artery bypass grafting is required, clopidogrel or ticagrelor should be stopped, and surgery should be delayed for at least 5 days."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
"If the decision is made to withhold a P2Y",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"12"
]
},
" inhibitor until the time of angiography and a P2Y",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"12"
]
},
" inhibitor is desired, clopidogrel, ticagrelor, or prasugrel can be initiated."
],
[
"Recommendations based on Amsterdam EA, Wenger NK, Brindis RG, et al; ACC/AHA Task Force Members. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:2354-94. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/25249586",
"target":"_blank"
},
"children":[
"PMID: 25249586"
]
},
" doi:10.1161/CIR.0000000000000133"
]
],
"imageInfo":{
"hash":"1e3f1035647c3c02e28d4a33e71b4f95",
"height":526,
"width":529,
"extension":"svg",
"vector":true
}
}